114 related articles for article (PubMed ID: 10836301)
1. Clinical evidence of distinct subgroups of astrocytic tumors defined by comparative genomic hybridization.
Nishizaki T; Kubota H; Harada K; Harada K; Ito H; Suzuki M; Sasaki K
Hum Pathol; 2000 May; 31(5):608-14. PubMed ID: 10836301
[TBL] [Abstract][Full Text] [Related]
2. [Study on the expression of epidermal growth factor receptor and p53 in astrocytic gliomas: evidence for a distinct genetic pathway].
Dong L; Pu PY; Wang H; Wang GX; Kang CS; Jiao DR
Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):232-6. PubMed ID: 16776982
[TBL] [Abstract][Full Text] [Related]
3. Investigation of genetic alterations associated with the grade of astrocytic tumor by comparative genomic hybridization.
Nishizaki T; Ozaki S; Harada K; Ito H; Arai H; Beppu T; Sasaki K
Genes Chromosomes Cancer; 1998 Apr; 21(4):340-6. PubMed ID: 9559346
[TBL] [Abstract][Full Text] [Related]
4. Whole-genome analysis of human astrocytic tumors by comparative genomic hybridization.
Maruno M; Ninomiya H; Ghulam Muhammad AK; Hirata M; Kato A; Yoshimine T
Brain Tumor Pathol; 2000; 17(1):21-7. PubMed ID: 10982006
[TBL] [Abstract][Full Text] [Related]
5. Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression.
Reifenberger J; Ring GU; Gies U; Cobbers L; Oberstrass J; An HX; Niederacher D; Wechsler W; Reifenberger G
J Neuropathol Exp Neurol; 1996 Jul; 55(7):822-31. PubMed ID: 8965097
[TBL] [Abstract][Full Text] [Related]
6. p53 protein and epidermal growth factor receptor expression in human astrocytomas.
Kordek R; Biernat W; Alwasiak J; Maculewicz R; Yanagihara R; Liberski PP
J Neurooncol; 1995 Oct; 26(1):11-6. PubMed ID: 8583240
[TBL] [Abstract][Full Text] [Related]
7. Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases.
Rickert CH; Sträter R; Kaatsch P; Wassmann H; Jürgens H; Dockhorn-Dworniczak B; Paulus W
Am J Pathol; 2001 Apr; 158(4):1525-32. PubMed ID: 11290570
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of the expression of tumor suppressor genes p53, p21, p16 and prb, and Ki-67 labelling in high grade astrocytomas treated with radiotherapy.
Kirla R; Salminen E; Huhtala S; Nuutinen J; Talve L; Haapasalo H; Kalimo H
J Neurooncol; 2000; 46(1):71-80. PubMed ID: 10896207
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.
Watanabe K; Tachibana O; Sata K; Yonekawa Y; Kleihues P; Ohgaki H
Brain Pathol; 1996 Jul; 6(3):217-23; discussion 23-4. PubMed ID: 8864278
[TBL] [Abstract][Full Text] [Related]
10. p53 protein overexpression in astrocytic neoplasms.
Cho MY; Jung SH; Kim TS
Yonsei Med J; 1995 Dec; 36(6):521-6. PubMed ID: 8599254
[TBL] [Abstract][Full Text] [Related]
11. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
Lang FF; Miller DC; Koslow M; Newcomb EW
J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
[TBL] [Abstract][Full Text] [Related]
12. p53 mutations versus EGF receptor expression in giant cell glioblastomas.
Peraud A; Watanabe K; Plate KH; Yonekawa Y; Kleihues P; Ohgaki H
J Neuropathol Exp Neurol; 1997 Nov; 56(11):1236-41. PubMed ID: 9370234
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor and proliferating cell nuclear antigen in astrocytomas.
Maiti AK; Ghosh K; Chatterjee U; Chakrobarti S; Chatterjee S; Basu S
Neurol India; 2008; 56(4):456-62. PubMed ID: 19127042
[TBL] [Abstract][Full Text] [Related]
14. Amplification of the epidermal growth factor receptor in astrocytic tumours by chromogenic in situ hybridization: association with clinicopathological features and patient survival.
Järvelä S; Helin H; Haapasalo J; Järvelä T; Junttila TT; Elenius K; Tanner M; Haapasalo H; Isola J
Neuropathol Appl Neurobiol; 2006 Aug; 32(4):441-50. PubMed ID: 16866989
[TBL] [Abstract][Full Text] [Related]
15. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis.
Kajiwara Y; Yamasaki F; Hama S; Yahara K; Yoshioka H; Sugiyama K; Arita K; Kurisu K
Cancer; 2003 Feb; 97(4):1077-83. PubMed ID: 12569609
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors.
Cheng Y; Ng HK; Ding M; Zhang SF; Pang JC; Lo KW
J Neuropathol Exp Neurol; 1999 Feb; 58(2):120-8. PubMed ID: 10029095
[TBL] [Abstract][Full Text] [Related]
17. Genetic subgroups of anaplastic astrocytomas correlate with patient age and survival.
Kunwar S; Mohapatra G; Bollen A; Lamborn KR; Prados M; Feuerstein BG
Cancer Res; 2001 Oct; 61(20):7683-8. PubMed ID: 11606412
[TBL] [Abstract][Full Text] [Related]
18. A2B5 lineages of human astrocytic tumors and their recurrence.
Xia CL; Du ZW; Liu ZY; Huang Q; Chan WY
Int J Oncol; 2003 Aug; 23(2):353-61. PubMed ID: 12851684
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathogenesis of pediatric astrocytic tumors.
Nakamura M; Shimada K; Ishida E; Higuchi T; Nakase H; Sakaki T; Konishi N
Neuro Oncol; 2007 Apr; 9(2):113-23. PubMed ID: 17327574
[TBL] [Abstract][Full Text] [Related]
20. Role of p53 immunohistochemistry in differentiating reactive gliosis from malignant astrocytic lesions.
Yaziji H; Massarani-Wafai R; Gujrati M; Kuhns JG; Martin AW; Parker JC
Am J Surg Pathol; 1996 Sep; 20(9):1086-90. PubMed ID: 8764745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
